Mucosal Bacille Calmette-Guérin Vaccination of Humans Inhibits Delayed-Type Hypersensitivity to Purified Protein Derivative but Induces Mycobacteria-Specific Interferon-γ Responses
Open Access
- 1 June 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (Supplement) , S217-S222
- https://doi.org/10.1086/313864
Abstract
We conducted a placebo-controlled, double-dose-escalation trial of oral bacille Calmette-Guérin (BCG) vaccination in 48 healthy volunteers. Seven ofKeywords
This publication has 26 references indexed in Scilit:
- Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin InfectionNew England Journal of Medicine, 1996
- A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial InfectionNew England Journal of Medicine, 1996
- Functional diversity of helper T lymphocytesNature, 1996
- Immune Response to Recombinant Mycobacterial Proteins in Patients with Tuberculosis Infection and DiseaseThe Journal of Infectious Diseases, 1996
- Immune Responses Stimulated by Percutaneous and Intradermal Bacille Calmette-GuerinThe Journal of Infectious Diseases, 1996
- An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.The Journal of Experimental Medicine, 1993
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.The Journal of Experimental Medicine, 1993
- T Cell Response to Mycobacterium tuberculosisThe Journal of Infectious Diseases, 1993
- Defining Protective Responses to Pathogens: Cytokine Profiles in Leprosy LesionsScience, 1991
- Role of Cytokines and CD4+ T‐Cell Subsets in the Regulation of Parasite Immunity and DiseaseImmunological Reviews, 1989